Ajay Goel, PhD, AGAF, professor and chair, Department of Molecular Diagnostics and Experimental Therapeutics, City of Hope, discusses upcoming clinical studies examining the prognostic biomarker CA19-9 in combination with an investigational exosome-based liquid biopsy for the detection of early-stage pancreatic cancer.

Dr Goel on the Future of an Exosome-Based Liquid Biopsy Plus the Biomarker CA19-9 to Detect Early-Stage Pancreatic Cancer

Videos

Ajay Goel, PhD, AGAF, discusses upcoming clinical studies examining the prognostic biomarker CA19-9 plus an investigational exosome-based liquid biopsy for the detection of early-stage pancreatic cancer.

Ajay Goel, PhD, AGAF

Articles

Dr Goel on the Future of an Exosome-Based Liquid Biopsy Plus the Biomarker CA19-9 to Detect Early-Stage Pancreatic Cancer